Abstract:Many activities of magnesium have justified randomized controlled trials of its role in acute myocardial infarction (AMI), which have shown reduction of short term mortality by 25% to over 50%. The Fourth International Study of Infarct Survival (ISIS-4) megastudy failed to confirm these findings, and, based on analysis of pooled findings, it was concluded that magnesium has no place in treatment of AMI. The fixed effects statistical model employed in ISIS-4 for evaluation of pooled data is inappropriate because the studies were not homogeneous. Among the differences between the earlier studies and the megatrial, the most significant was the time at which magnesium infusions were started relative to the time of reperfusion. Animal studies have shown that magnesium is protective only if present before or at the time of reperfusion. Unlike in earlier trials, in which magnesium infusions were started soon after the ischemic event or simultaneously with a lytic agent, in ISIS-4 magnesium treatment was withheld until after iatrogenic or spontaneous reperfusion occurred. This can explain poor therapeutic results in ISIS-4, but not the hypotension and bradycardia encountered in a minority of patients in that study. Dosage difference alone cannot explain this, even though the amounts given in the small studies were 40% to 25% less than that in ISIS-4, because the dose used in the Second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) was only slightly lower than that used in ISIS-4. Administration of high dose magnesium with an angiotensin-converting enzyme inhibitor (which spares magnesium) or the vasodilating oral nitrate in arms of ISIS-4 may have contributed to adverse effects of hypermagnesemia. Also, the very low mortality rate of controls in ISIS-4 suggests that the patients may have been at relatively low risk, and it is in high risk patients that magnesium has been shown to be most effective. A large scale study of magnesium in such patients is being started.

Incubators in Neonatal Medicine

Optimizing the neonatal thermal environment

Healthful environments for hospitalized infants

Entertaining and instructing the public: John Zahorsky's 1904 incubator institute

Magnesium in acute myocardial infarction: still an open question.

Construction of a Low-cost Mobile Incubator for Field and Laboratory Use

A double-walled incubator alters the partition of body heat loss of premature infants

Living in a box: Understanding acoustic parameters in the NICU environment

Imaging the neonate in the incubator: an investigation of the technical, radiological and nursing issues

Evolution of mechanical ventilation of the newborn infant

Saving More Neonates in Hospital: An Intervention towards a Sustainable Reduction in Neonatal Mortality in a Nicaraguan Hospital

Study on the Concept and Development of a Mobile Incubator

Effects of an early transfer from incubator to a warming crib in very low birthweight preterm infants

Development of an artificial placenta for support of premature infants: narrative review of the history, recent milestones, and future innovation

Embryology and endocrinology of genital development.

Ubiquitylation Directly Induces Fold Destabilization of Proteins

Low Fasting Oxytocin Levels Are Associated With Psychopathology in Anorexia Nervosa in Partial Recovery.

Prevention of NICU Admission Hypothermia in Moderate- and Late-Preterm Infants

From intra- to extra-uterine: early phase design of a transfer to extra-uterine life support through medical simulation

Introduction of a novel neonatal warming device in Malawi: an implementation science study

"Every breath you take": evaluating sound levels and acoustic characteristics of various neonatal respiratory support and ventilation modalities